Markets:

Overview

News

Currencies

International

Treasuries

ResMed Inc. Common Stock (NY:RMD)

193.97 -4.47 (-2.25%)

Streaming Delayed Price Updated: 2:18 PM EDT, Jun 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

19 20 Next >

Peering Into ResMed's Recent Short Interest ↗

March 26, 2024

Via Benzinga

ASX : RMD - Resmed Stock Analysis & Elliott Wave Technical Forecast ↗

March 21, 2024

Our Elliott Wave analysis updates the Australian Stock Exchange with Resmed Inc shares. We have identified an Expanded Flat correction pattern, indicating the potential for RMD to continue declining...

Via Talk Markets

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

March 15, 2024

From ResMed Inc.

Via GlobeNewswire

Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask

March 06, 2024

From ResMed Inc.

Via GlobeNewswire

Why NYSE:RMD provides a good dividend, while having solid fundamentals. ↗

March 06, 2024

Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock.

Via Chartmill

Uncovering Dividend Opportunities with NYSE:RMD. ↗

February 12, 2024

Why RESMED INC (NYSE:RMD) provides a good dividend, while having solid fundamentals.

Via Chartmill

Cracking The Code: Understanding Analyst Reviews For ResMed ↗

January 25, 2024

Via Benzinga

Got $1,000? Buy These Hot Growth Stocks Before They Take Off ↗

February 22, 2024

If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode.

Via The Motley Fool

ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea

February 12, 2024

From ResMed Inc.

Via GlobeNewswire

MatrixCare Earns Three 2024 Best in KLAS Awards

February 07, 2024

MatrixCare has been named a market leader by KLAS Research for its Home Health EHR in three Categories: Home Health – Independent – Large, Home Health – Independent – Small, and Hospice – Independent

From MatrixCare

Via GlobeNewswire

Why ResMed Stock Is Jumping Today ↗

January 25, 2024

The medical device maker beat expectations with its latest quarterly results.

Via The Motley Fool

Recap: ResMed Q2 Earnings ↗

January 24, 2024

Via Benzinga

ResMed's Earnings: A Preview ↗

January 23, 2024

Via Benzinga

Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years ↗

February 01, 2024

Via Benzinga

ResMed Flexes Its Operating Muscle, Sends Shares Flying Above Their 200-Day Line ↗

January 25, 2024

ResMed reported better-than-expected sales and adjusted earnings.

Via Investor's Business Daily

AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday ↗

January 25, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024

January 24, 2024

From ResMed Inc.

Via GlobeNewswire

Why NYSE:RMD provides a good dividend, while having solid fundamentals. ↗

January 17, 2024

Exploring RESMED INC (NYSE:RMD)'s dividend characteristics.

Via Chartmill

If You Invested $100 In This Stock 15 Years Ago, You Would Have $900 Today ↗

January 10, 2024

Via Benzinga

Demystifying ResMed: Insights From 5 Analyst Reviews ↗

January 09, 2024

Via Benzinga

Uncovering Dividend Opportunities with NYSE:RMD. ↗

December 26, 2023

Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock.

Via Chartmill

Earnings Scheduled For January 24, 2024 ↗

January 24, 2024

Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion.

Via Benzinga

$1000 Invested In ResMed 15 Years Ago Would Be Worth This Much Today ↗

December 25, 2023

Via Benzinga

(RMD) - Analyzing ResMed's Short Interest ↗

December 22, 2023

Via Benzinga

3 Stocks to Buy to Benefit From the Booming Sleep Industry ↗

January 23, 2024

It’s not easy to find sleep stocks to buy despite the fact the industry is booming these days from society's lack of rest and relaxation.

Via InvestorPlace

FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious ↗

January 12, 2024

ResMed (NYSE: RMD) recalls certain respiratory masks with magnets due to potential interference with medical devices. FDA Class I recall.

Via Benzinga

Topics Product Recall

HCA Healthcare Rallies: Weight-loss drugs really a big threat?

January 08, 2024

HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.

Via MarketBeat

Topics ETFs

Top Picks 2024: ResMed ↗

January 07, 2024

ResMed is the market leader in continuous positive airway pressure machines. ResMed has enjoyed a steadily growing market throughout its history, and investors have often paid sky-high valuations for...

Via Talk Markets

ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024

January 03, 2024

From ResMed Inc.

Via GlobeNewswire

ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference

December 27, 2023

From ResMed Inc.

Via GlobeNewswire

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.